Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy
J Clin Endocrinol Metab
.
2001 Jan;86(1):16-23.
doi: 10.1210/jcem.86.1.7269.
Authors
R J Santen
1
,
J Pinkerton
,
C McCartney
,
G R Petroni
Affiliation
1
University of Virginia Health System, Departments of Medicine, Charlottesville, Virginia 22908, USA.
PMID:
11231971
DOI:
10.1210/jcem.86.1.7269
No abstract available
Publication types
Review
MeSH terms
Breast Neoplasms / chemically induced*
Drug Therapy, Combination
Estrogens / adverse effects*
Female
Hormone Replacement Therapy* / adverse effects*
Humans
Progestins / adverse effects*
Risk Factors
Substances
Estrogens
Progestins